Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0200-2027

Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Recall

Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P Product Description: Greiner VACUETTE Blood Collection Tube with Lithium Heparin and Gel Separator (13 x 75 mm, 3.5ml)

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0200-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 29, 2026
FDA report date
Oct 28, 2026
Quantity in commerce
860450
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P Product Description: Greiner VACUETTE Blood Collection Tube with Lithium Heparin and Gel Separator (13 x 75 mm, 3.5ml)

Affected model & UDI checker

Search the exact identifiers published for Z-0200-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
454008PBrand Name: VACUETTE Product Name: LH Lithium Heparin SeparatorCheck source noticeNot specified
FDA code information

Lot Code: Item Number: 454008P Lot Number: B26043FM UDI: Rack: 29120017579032, Case: 39120017579039 Expiration Date: 2027-07-12

View the original FDA recall notice

Why was this product recalled?

Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the potential to cause hyperkalemia.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Greiner Bio-One North America, Inc. take?

On 07/29/2026, an "URGENT MEDICAL DEVICE RECALL NOTICE" was emailed to customers informing them that, Greiner Bio-One North America identified a potential ethylenediaminetetraacetic acid (EDTA) contamination issue in a specific lot of VACUETTE Lithium Heparin serum separator tubes. Use of affected tubes may lead to: " Falsely elevated potassium (K+) results " Falsely decreased calcium (Ca++) results Customers are instructed to: " Immediately identify and quarantine all remaining units of item 454008P, lot B26043FM. " Stop using the affected lot for blood collection. " Notify relevant staff (phlebotomy, lab, clinical teams) of this advisory. " Review any recent patient results obtained using this lot. Consider repeat testing with a different lot if results appear inconsistent with clinical presentation. " Follow proper order of draw, and recollection procedures when re-testing. For unused product disposal (if destroyed by customer/distributor) " The unused blood collection tubes contain chemical additives (LH and serum separator). Recommend following OSHA process, and/or your facility's environmental health and safety (EHS) policies and procedures for disposal. For questions or documentation (Acknowledgement and Receipt Form) to Recalls.US@gbo.com or please call 800-515-8112.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology